Recent Blog Posts

View Post: MedWire News - Respiratory - Omalizumab benefits Asian asthma patients
26 Nov 2009
MedWire News Omalizumab improves disease control in Asian patients with moderate-to-severe asthma without causing any significant adverse events, researchers report in findings that are consistent with those from studies conducted in ...
View Blog: MedWire News - Respiratory - http://www.medwire-news.md/48/Respiratory.html

---

View Post: FDA panel rejects omalizumab (Xolair®) for treatment of asthma in ...
20 Nov 2009
An advisory panel to the FDA has voted 10 to 4 against approval of omalizumab (Xolair®) for the treatment of asthma in children aged 6 to 11 years. The committee was split evenly on the effectiveness of the drug but voted by 9 to 5 that ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: Omalizumab for Allergic Asthma Treatment
1 Dec 2009 by The Alternate Medic  
Allergic asthma is the display of asthma symptoms as a part of an allergic reaction. Inadvertent inhalation of allergens or ingestion of food proteins can trigger some people's immune system to overreact and IgE to bind to mast cells. ...
View Blog: Cinese Medicine - http://www.chinamedics.com/

---

View Post: Omalizumab for the treatment of exacerbations in children with ...
12 Nov 2009 by Bob Lanier, Tracy Bridges, Marek Kulus,...  
This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in children with moderate-to-severe persistent allergic (IgE-mediated) asthma that was inadequately controlled despite treatment with medium-dose or ...
View Blog: The Journal of Allergy and Clinical Immunology... - http://www.jacionline.org/inpress?rss=yes

---

View Post: Omalizumab for asthma
17 Nov 2009
The US Food and Drug Administration said studies with the asthma drug Xolair, omalizumab marketed by Novartis AG (NVS) and Genentech, showed it has "modest" benefits in children ages six to 11. ...
View Blog: Current R&D of Pharmaceutical - http://www.cradop.com/component/content/frontpage.html

---

View Post: Cat Allergy Clinical Trial: The Effects of Omalizumab (Anti-IgE ...
26 Oct 2009
This arm will receive treatment with a placebo injections based on the FDA-approved dosing schedule approved for omalizumab for the treatment of allergic asthma.In general injection number and frequency are determined by a subject's ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Omalizumab for Allergic Asthma
1 Nov 2009 by admin  
In 2003, a medicine known as "Omalizumab" was approved for use against allergic asthma. It is also known as “Anti-IgE”. This drug is administered subcutaneously every 2 or 4 weeks. It got its nickname because Omalizumab binds free IgE ...
View Blog: Ionic Air Purifier Store - http://ionicairpurifierstore.com/

---

View Post: Allergy Notes: Omalizumab-associated anaphylactic reactions ...
4 Dec 2009 by Ves Dimov, MD  
19 reactions occurred within 1 hour of omalizumab injection. You can read our case description here: Anaphylactic Reaction to Omalizumab (Xolair) in a Patient with Severe Asthma. References: Omalizumab-associated anaphylactic reactions ...
View Blog: Allergy Notes - http://allergynotes.blogspot.com/

---

View Post: Effect of omalizumab on peripheral blood eosinophilia in allergic ...
21 Oct 2009 by M. Massanari, S.T. Holgate, W.W. Busse,...  
Summary: Eosinophilia is an established marker of asthma-related inflammation. We assessed the effect of omalizumab on peripheral blood eosinophil counts using a pooled analysis of data from five randomized, double-blind, ...
View Blog: Sc Scandium - http://sc-scandium.info/

---